+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating whether a digital care pathway DCP and asynchronous communication AC with a nurse can help treat high blood pressure in adults receiving primary care. The study compares usual care alone, usual care plus DCP, and usual care plus DCP with AC. It also aims to find out if these digital interventions are cost-effective. The trial is conducted as a cluster-randomized controlled study in six healthcare centers, involving about 600 adults aged 30 to 74 with hypertension. Participants will receive either usual care, usual care plus access to a digital care pathway app, or usual care plus the app combined with non-real-time messaging with a nurse, each for 6 months. The digital care pathway includes tools for goal setting, education, home blood pressure entry, medication tracking, reminders, motivational messages, and a health diary. Study nurses will support recruitment and monitoring, and healthcare professionals will use home blood pressure readings to optimize hypertension management. Participants will have visits with study nurses at the start and after 6 months for checkups and laboratory tests. They will also measure their blood pressure at home for 4 days at the beginning and end of the study, and complete online surveys about their health, medication adherence, quality of life, and perceptions of the digital tools. Researchers will track changes in systolic blood pressure, cardiovascular risk scores, healthcare use, and costs to understand the interventions effects and value.

Age: 30Years - 74YearsAll GendersPhase Not Applicable
6 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are investigating small-bowel diseases, focusing on celiac disease and other conditions causing mucosal injury. This observational study aims to establish reliable histological reference values for the normal small-bowel mucosa, improve diagnostic accuracy, and develop advanced molecular profiles to evaluate disease progression and treatment responses. The study recognizes the current variability and error rates in histological evaluations and seeks to enhance diagnostic quality through modern techniques. Participants are divided into three groups healthy controls undergoing gastroscopy with no celiac disease suspicion and negative antibodies, patients referred for primary celiac disease diagnostics requiring duodenal biopsy, and patients with refractory small-bowel mucosal injury unresponsive to a gluten-free diet. Duodenal biopsies are collected and analyzed using digital morphometry, AI-based image analysis, RNA sequencing, and intestinal organoid cultures. These processes occur at the research center under secure data handling. During the study, participants undergo routine clinical assessments, including standard pathology reviews of their biopsies. Researchers measure villus-to-crypt ratios and perform transcriptomic analyses to understand molecular changes. Additional evaluations include AI-driven image analyses and organoid modeling throughout the study period. Data is stored securely for 15 years. The study may last until December 2035, with primary outcome measures assessed up to December 2025 and ongoing molecular analyses extending through the entire period.

Age: 18Years +All Genders
3 locations